BRCA1 and neoplasm: It is important to note that blood collection in many of these previous studies was done at the time of cancer diagnosis, so DNA methylation could have been affected by the developing tumor; other studies included BRCA1 mutation carriers that were oversampled/represented in the cases but not in the controls.